MediPharm Labs Corp. said that German pharmaceutical company STADA Arzneimittel AG has signed an exclusive medical cannabis supply agreement with a wholly owned subsidiary of MediPharm.
Canada-based MediPharm Labs is a provider of cannabis oil and concentrates.
Under the terms of the deal, MediPharm will supply Good Manufacturing Practice or GMP-certified medical cannabis products to STADA, as well as provide manufacturing, logistics, and regulatory support.
STADA will be responsible for commercializing the cannabis products, initially in Germany. The German company will also be responsible for marketing and medical education by utilizing a pharmaceutically-experienced field force.
MediPharm Labs said that details of the products that STADA will bring to market through the partnership will be unveiled in the coming months. The partnership also signals MediPharm’s entry into the global pharmaceutical industry within a major European market.
“Working with MediPharm will meet the needs of…